CC
LLY icon

ClearArc Capital’s Eli Lilly LLY Stock Holding History

ClearArc Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.04M Sell
7,882
-3,733
-32% -$433K 0.4% 60
2019
Q3 		$1.3M Sell
11,615
-119
-1% -$13.2K 0.38% 60
2019
Q2 		$1.3M Sell
11,734
-1,439
-11% -$169K 0.38% 60
2019
Q1 		$1.71M Sell
13,173
-1,779
-12% -$216K 0.46% 54
2018
Q4 		$1.73M Sell
14,952
-11,019
-42% -$1.23M 0.52% 46
2018
Q3 		$2.79M Buy
25,971
+218
+0.8% +$21.8K 0.36% 72
2018
Q2 		$2.2M Buy
25,753
+3,786
+17% +$311K 0.31% 82
2018
Q1 		$1.7M Sell
21,967
-64
-0.3% -$5.15K 0.26% 95
2017
Q4 		$1.86M Buy
22,031
+84
+0.4% +$7.15K 0.25% 92
2017
Q3 		$1.88M Sell
21,947
-44
-0.2% -$3.61K 0.28% 84
2017
Q2 		$1.81M Buy
21,991
+48
+0.2% +$3.92K 0.29% 83
2017
Q1 		$1.85M Buy
21,943
+109
+0.5% +$8.73K 0.31% 80
2016
Q4 		$1.61M Sell
21,834
-236
-1% -$17.6K 0.29% 89
2016
Q3 		$1.77M Buy
22,070
+69
+0.3% +$5.52K 0.33% 72
2016
Q2 		$1.73M Sell
22,001
-80
-0.4% -$6.02K 0.34% 77
2016
Q1 		$1.59M Sell
22,081
-31
-0.1% -$2.35K 0.34% 72
2015
Q4 		$1.86M Buy
22,112
+200
+0.9% +$16.6K 0.39% 62
2015
Q3 		$1.83M Sell
21,912
-425
-2% -$35.9K 0.38% 65
2015
Q2 		$1.86M Buy
22,337
+2,492
+13% +$190K 0.34% 78
2015
Q1 		$1.44M Buy
19,845
+326
+2% +$23.2K 0.3% 95
2014
Q4 		$1.35M Buy
19,519
+671
+4% +$45.3K 0.28% 110
2014
Q3 		$1.22M Buy
18,848
+352
+2% +$22.3K 0.28% 108
2014
Q2 		$1.15M Buy
18,496
+73
+0.4% +$4.36K 0.27% 119
2014
Q1 		$1.08M Sell
18,423
-45
-0.2% -$2.51K 0.27% 112
2013
Q4 		$942K Sell
18,468
-476
-3% -$23.8K 0.24% 124
2013
Q3 		$953K Sell
18,944
-92
-0.5% -$4.82K 0.27% 113
2013
Q2 		$935K Buy
+19,036
New +$1.04M 0.25% 120

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearArc Capital's LLY Position: Q4 2019 in Review

ClearArc Capital reduced its Eli Lilly (LLY) stake by 32% in Q4 2019, selling an estimated $433K and leaving 7,882 shares worth $1.04M. The position accounts for 0.4% of the portfolio, ranked #60.

ClearArc Capital first reported a position in LLY in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.79M in Q3 2018. 1,673 funds tracked by Wall St. Rank hold LLY as of Q4 2019.

  • ClearArc Capital held 7,882 shares of Eli Lilly worth $1.04M as of Q4 2019.
  • ClearArc Capital sold 3,733 Eli Lilly shares in Q4 2019, an estimated $433K.
  • Eli Lilly made up 0.4% of ClearArc Capital's portfolio in Q4 2019, its #60 holding.
  • ClearArc Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Eli Lilly position peaked at $2.79M in Q3 2018.
  • 1,673 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.